Fangsheng Pharmaceutical: Net profit in the first half of 2025 increased by 23.67% year-on-year
Fangsheng Pharmaceutical announced that its operating revenue in the first half of 2025 was 834 million yuan, a year-on-year decrease of 8.35%. The net profit was 169 million yuan, a year-on-year increase of 23.67%. The company plans to distribute a cash dividend of 1.5 yuan for every 10 shares to all shareholders
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments